Related Experiment Video
Updated: Jul 17, 2026

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions
Published on: September 17, 2014
Design and in vitro evaluation of floating drug delivery system for an antipsychotic agent: a technical report
1Dept of Pharmacy, Mohanlal Sukhadia University, Udaipur, India. karmousumi@hotmail.com
Abstract:
Floating drug delivery systems are used to target drug release in the stomach or to the upper parts of the intestine. The oral delivery of the anti-psychotic agent carbamazepine was facilitated by preparing a non-disintegrating floating dosage form which can increase its absorption in the stomach by increasing the drug's gastric residence time. The polymers used were HPMC (low and high viscosity), guar gum, and carbopol, along with sodium bicarbonate as the gas-generating agent. The prepared tablets were evaluated for their physicochemical properties and drug release. In vitro release studies indicated that the carbamazepine release from the floating dosage forms was uniform and followed a zero-order release. It was observed that the devices containing higher proportions of HPMC (high viscosity) showed slower release than those containing lower proportions while also maintaining the integrity of the device (> or = 24 h). The incorporation of guar gum helps to maintain the device's integrity, and due to its viscolysing property also affects the drug's release profile. Sodium bicarbonate which was used as the gas-generating agent causes the tablet to float for the required time (> or = 24 h).
Related Concept Videos
In Vitro Drug Dissolution: Alternative Methods
Oral Drug Delivery Systems: Continuous-Release Systems
In Vitro Drug Dissolution: Compendial Testing Models I
Modified-Release Drug Delivery Systems: Rate-Programmed II
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Modified-Release Drug Delivery Systems: Bioavailability
